Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |